Expanding role of lenalidomide in hematologic malignancies

Expanding role of lenalidomide in hematologic malignancies

Nilanjan Ghosh, Michael R Grunwald, Omotayo Fasan, Manisha Bhutani Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA Abstract: Lenalidomide is an immunomodulatory agent that has been approved by the US Food and Drug Administration for treatment of multiple myeloma, deletion 5...

Full description

Bibliographic Details
Main Authors:	Ghosh N, Grunwald MR, Fasan O, Bhutani M
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-05-01
Series:	Cancer Management and Research
Online Access:	http://www.dovepress.com/expanding-role-of-lenalidomide-in-hematologic-malignancies-peer-reviewed-article-CMAR

Similar Items

Mechanism of action of lenalidomide in hematological malignancies
by: Kotla Venumadhav, et al.
Published: (2009-08-01)

Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship
by: Zaiwei Song, et al.
Published: (2022-06-01)

The roles of TPL in hematological malignancies
by: Tingyun Xu, et al.
Published: (2023-12-01)

Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies
by: McBride Ali, et al.
Published: (2012-12-01)

Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia
by: Bernadene Fernandopulle, et al.
Published: (2010-05-01)

Role of Notch Receptors in Hematologic Malignancies
by: Laura Gragnani, et al.
Published: (2020-12-01)

Multiple Roles of Glycans in Hematological Malignancies
by: Xingchen Pang, et al.
Published: (2018-09-01)

Role of CD47 in Hematological Malignancies
by: Entsar Eladl, et al.
Published: (2020-07-01)

Roles of circRNAs in hematological malignancies
by: Fahua Deng, et al.
Published: (2022-07-01)

Update on the role of copanlisib in hematologic malignancies
by: Thuy Le, et al.
Published: (2021-04-01)

Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma
by: C. Cerchione, et al.
Published: (2020-10-01)

Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
by: Pasquale Niscola
Published: (2014-08-01)

The Role of Tumor-Associated Macrophages in Hematologic Malignancies
by: Emanuele Cencini, et al.
Published: (2021-07-01)

Role of Circulating Tumor DNA in Hematological Malignancy
by: Miho Ogawa, et al.
Published: (2021-04-01)

The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies
by: Neha Sarodaya, et al.
Published: (2020-04-01)

The Role of RNA-Binding Proteins in Hematological Malignancies
by: Pedro Aguilar-Garrido, et al.
Published: (2022-08-01)

Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies
by: Yasharah Raza, et al.
Published: (2022-10-01)

Role of Wnt canonical pathway in hematological malignancies
by: Wang Xin, et al.
Published: (2010-09-01)

Novel Molecular Mechanism of Lenalidomide in Myeloid Malignancies Independent of Deletion of Chromosome 5q
by: Isaac Park, et al.
Published: (2021-10-01)

The role of CD180 in hematological malignancies and inflammatory disorders
by: Kurtis Edwards, et al.
Published: (2023-07-01)

Aspergillosis in patients with hematological malignancies
by: N. B. Bulieva
Published: (2014-07-01)

Aspergillosis in patients with hematological malignancies
by: N. B. Bulieva
Published: (2014-07-01)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
by: Hermann Einsele, et al.
Published: (2020-08-01)

P1264: HEMATOPOIETIC CLONES WITH TP53 MUTATIONS EXPAND IN PATIENTS WITH MCL DURING LENALIDOMIDE-BASED THERAPY
by: S. Husby, et al.
Published: (2022-06-01)

HEMATOLOGICAL MALIGNANCIES. LYMPHOCYTIC LEUKAEMIA
by: Peter F. Litvitsky, et al.
Published: (2016-11-01)

Autophagy in Hematological Malignancies
by: Olga García Ruiz, et al.
Published: (2022-10-01)

Carbamazepine and Hematological Malignancies
by: İrfan Yavaşoğlu, et al.
Published: (2013-12-01)

Eponyms in Malignant Hematology
by: Danielle Brazel, et al.
Published: (2022-01-01)

Neoantigens in Hematologic Malignancies
by: Melinda A. Biernacki, et al.
Published: (2020-02-01)

Deubiquitinases in hematological malignancies
by: Hu Lei, et al.
Published: (2021-08-01)

Advances in malignant hematology /
by: Saba, Hussain I. 536043, et al.
Published: (2011)

Candidiasis in hematologic malignancies
by: V. B. Larionova, et al.
Published: (2022-11-01)

Myeloid hematological malignancies
by: D. A. Domninsky
Published: (2014-07-01)

Lymphoid hematological malignancies
by: D. A. Domninskiy
Published: (2014-07-01)

Lymphoid hematological malignancies
by: D. A. Domninskiy
Published: (2014-07-01)

Myeloid hematological malignancies
by: D. A. Domninsky
Published: (2014-07-01)

Critical Role of Aquaporins in Cancer: Focus on Hematological Malignancies
by: Alessandro Allegra, et al.
Published: (2022-08-01)

Roles and Regulation of BCL-xL in Hematological Malignancies
by: Mario Morales-Martínez, et al.
Published: (2022-02-01)

The role of interleukin-15 in the development and treatment of hematological malignancies
by: Paola Sindaco, et al.
Published: (2023-04-01)

Emerging roles of epithelial-mesenchymal transition in hematological malignancies
by: San-Chi Chen, et al.
Published: (2018-04-01)